EVOTEC News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

23.07.24	EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
11.07.24	EQS-NVR: Evotec SE: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 41 WpHG mit dem Ziel der europaweiten Verbreitung (EQS Group)
11.07.24	EQS-NVR: Evotec SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
10.07.24	EQS-News: Evotec und Pfizer arbeiten zusammen, um Wirkstoffforschung in Frankreich voranzubringen (EQS Group)
10.07.24	EQS-News: Evotec and Pfizer collaborate to advance drug discovery in France (EQS Group)
08.07.24	EQS-News: Just – Evotec Biologics expands tech partnership for biosimilars with Sandoz (EQS Group)
08.07.24	EQS-News: Just – Evotec Biologics erweitert Tech-Partnerschaft für Biosimilars mit Sandoz (EQS Group)
05.07.24	EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
04.07.24	EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
01.07.24	EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
27.06.24	EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
26.06.24	EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
25.06.24	EQS-News: Just – Evotec Biologics vom US-amerikanischen Verteidigungsministerium für Manufacturing Optimization Program ausgewählt (EQS Group)
25.06.24	EQS-News: Just – Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program (EQS Group)
12.06.24	EQS-News: Evotec gibt Fortschritt in Neurologie-Partnerschaft mit Bristol Myers Squibb bekannt (EQS Group)
12.06.24	EQS-News: Evotec announces progress in neuroscience collaboration with Bristol Myers Squibb (EQS Group)
10.06.24	EQS-News: Evotec SE: Ergebnisse der Hauptversammlung 2024 (EQS Group)
10.06.24	EQS-News: Evotec SE: Results of the Annual General Meeting 2024 (EQS Group)
04.06.24	EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
30.05.24	EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
30.05.24	EQS-News: Evotec, Inserm, Lille University Hospital und Inserm Transfert arbeiten zusammen, um neue therapeutische Ziele bei Adipositas und Stoffwechselerkrankungen zu identifizieren (EQS Group)
30.05.24	EQS-News: Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration to identify novel therapeutic targets in obesity and metabolic diseases (EQS Group)
28.05.24	EQS-News: Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington’s disease (EQS Group)
28.05.24	EQS-News: Evotec und CHDI Foundation verlängern strategische Huntington-Allianz (EQS Group)
27.05.24	EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
27.05.24	EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
24.05.24	EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
22.05.24	EQS-News: Evotec SE: Ergebnisse für das erste Quartal 2024 und Update zur Unternehmensentwicklung (EQS Group)
22.05.24	EQS-News: Evotec reports Q1 2024 results and provides corporate update (EQS Group)
21.05.24	EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
16.05.24	EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
15.05.24	EQS-News: Evotec SE to announce results for first quarter 2024 on 22 may 2024 (EQS Group)
15.05.24	EQS-News: Evotec SE: Bekanntgabe der Ergebnisse für das erste Quartal 2024 am 22. Mai 2024 (EQS Group)
14.05.24	EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
14.05.24	EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
13.05.24	EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
08.05.24	EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
07.05.24	EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
06.05.24	EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
03.05.24	EQS-DD: Evotec SE: Dr. Cord Dohrmann, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2023 pursuant Evotec’s remuneration system. (EQS Group)
03.05.24	EQS-DD: Evotec SE: Dr. Cord Dohrmann, Gesperrte Aktien gewährt als kurzfristige variable Vergütung (Bonus) für 2023 gemäß Evotecs Vergütungssystem. (EQS Group)
03.05.24	EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
03.05.24	EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
03.05.24	EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
03.05.24	EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group)
30.04.24	EQS-News: Bayer und Evotec vereinbaren Forschungskollaboration in der Präzisionskardiologie (EQS Group)
30.04.24	EQS-News: Bayer and Evotec collaborate to advance precision cardiology (EQS Group)
24.04.24	EQS-News: Evotec SE stellt Ergebnisse für das Geschäftsjahr 2023 vor und richtet Priorität auf profitables Wachstum aus (EQS Group)
24.04.24	EQS-News: Evotec presents fiscal year 2023 results and announces priority reset to focus on profitable growth (EQS Group)
23.04.24	EQS-News: Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer (EQS Group)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

17:58		Freundlicher Handel: TecDAX letztendlich im Plus
17:58		Gute Stimmung in Zürich: Anleger lassen SPI schlussendlich steigen
17:58		Zuversicht in Frankfurt: LUS-DAX beendet die Donnerstagssitzung im Plus
17:58		SDAX aktuell: SDAX zum Handelsende auf grünem Terrain
17:58		Gewinne in Frankfurt: Letztendlich Pluszeichen im DAX
17:56		Novartis-Aktie fester: Novartis passt Umsatzziele nach oben an
16:17		Roche-Aktie stabil: Swissmedic genehmigt subkutane Version von Ocrevus
15:58		Minuszeichen in Frankfurt: SDAX am Nachmittag leichter